Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial
Albain, Kathy S, Prof, Barlow, William E, Prof, Ravdin, Peter M, Prof, Farrar, William B, Prof, Burton, Gary V, Prof, Ketchel, Steven J, MD, Cobau, Charles D, MD, Levine, Ellis G, MD, Ingle, James N, Prof, Pritchard, Kathleen I, Prof, Lichter, Allen S, Prof, Schneider, Daniel J, MD, Abeloff, Martin D, Prof, Henderson, I Craig, Prof, Muss, Hyman B, Prof, Green, Stephanie J, Prof, Lew, Danika, MA, Livingston, Robert B, Prof, Martino, Silvana, DO, Osborne, C Kent, Prof
Published in The Lancet (British edition) (19.12.2009)
Published in The Lancet (British edition) (19.12.2009)
Get full text
Journal Article
Effects of adjuvant exemestane versus anastrozole on bone mineral density for women with early breast cancer (MA.27B): a companion analysis of a randomised controlled trial
Goss, Paul E, Prof, Hershman, Dawn L, Prof, Cheung, Angela M, Prof, Ingle, James N, Prof, Khosla, Sundeep, MD, Stearns, Vered, Prof, Chalchal, Haji, MD, Rowland, Kendrith, Prof, Muss, Hyman B, Prof, Linden, Hannah M, Prof, Scher, Judite, MSc, Pritchard, Kathleen I, Prof, Elliott, Catherine R, MSc, Badovinac-Crnjevic, Tanja, MD, St Louis, Jessica, BA, Chapman, Judith-Anne W, Prof, Shepherd, Lois E, Prof
Published in The lancet oncology (01.04.2014)
Published in The lancet oncology (01.04.2014)
Get full text
Journal Article